In patients with severe, refractory hyperemesis gravidarum, two off label medications were associated with rapid and clinically meaningful reductions in nausea, vomiting, and weight loss.
Objective:
To evaluate the effectiveness of two off-label medications for managing hyperemesis gravidarum (HG) unresponsive to standard therapies.
Authors:
Andrew Housholder, MD, The HG and Morning Sickness Clinic
Marlena Fezjo, Ph.D, USC, Keck School of Medicine, HER Foundation
Ellie Lewis, John Hopkins University
Isabella Clements, UAB
Thank you to Kimber MacGibbon, MS, BSN, RN and Aimée Brecht-Doscher, MD, both from the HER Foundation, for reviewing this abstract prior to publication.
Presented at SMFM in February 2026